Gotham City Research make over 20 million after sinking Grifols’ share price but don’t seem to be discovering anything really new
Following the accusations made by Gotham City Research about alleged accounting irregularities at GRIFOLS (GRF), where on Monday it declared 0.5% of its capital in short positions, the plasma derivatives multinational sent a new statement to the CNMV (National Securities Market Commission) yesterday afternoon in which it denied the main arguments of the bearish investment firm. GRF stresses that all the information is contained in public documents submitted to the…









